Latest IMPACT developments
The following research centres are actively recruiting participants into the IMPACT study:
UK
The Royal Marsden NHS Foundation Trust, Surrey & London, UK
Wessex Clinical Genetics Service, The Princess Anne Hospital, Southampton, UK
Regional Genetics Service, St Mary’s Hospital, Manchester, UK
Churchill Hospital, Oxford, UK
The Genetics Unit, Addenbrookes NHS Trust, Cambridge, UK
St Michael’s Hospital, Bristol, UK
Institute of Human Genetics, Newcastle, UK
Royal Devon and Exeter Foundation Trust, Exeter, UK
Sheffield Children's Hospital, Sheffield, UK
Aberdeen Royal Infirmary, Aberdeen, UK
Royal Liverpool Children's Hospital, Liverpool, UK
Birmingham Women's Hospital, Birmingham, UK
Leicester Royal Infirmary, Leicester, UK
Australia
Peter MacCallum Cancer Institute, Victoria, Australia
Royal Melbourne Hospital Familial Cancer Centre, Melbourne, Australia
Familial Cancer Unit, SA Clinical Genetics Service, North Adelaide, Australia
Westmead Hospital, Sydney, Australia
Prince of Wales Hospital, Sydney, Australia
King Edward Memorial Hospital, Australia
Hunter New England Health, Australia
Monash Medical Centre, Australia
Europe
Vejle Hospital, Vejle, Denmark
Istituto Nazionale dei Tumori, Milan, Italy
Norwegian Radium Hospital, Oslo, Norway
International Hereditary Cancer Centre, Szczecin, Poland
National Cancer Institute, Bratislava, Slovak Republic
Institute of Oncology, Ljubljana, Slovenia
Catalonian Institute of Oncology, Barcelona, Spain
Sevei Oncologia Medica, Barcelona, Spain
Karolinska Universitetssjukhuset i Solna, Stockholm, Sweden
USA
University of Utah, Salt Lake City, USA
Abramson Cancer Centre, Philadelphia, USA
NorthShore University HealthSystem, Evanston, USA
MD Anderson Cancer Centre, Houston, Texas, USA
Israel
Chaim Shema Medical Center, Israel
Malaysia
Cancer Reserach Initiatives Foundation, Subang Jaya Medical Centre, Malaysia
Canada
McGill University/ Jewish General Hospital, Montreal, Quebec
The following research centres are due to start recruiting patients in the near future.
The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus
Abt. Molekulare Gynäko-Onkologie (Zentrum Familiaerer Brust- und Eierstockkrebs), Heidelberg, Germany
Centro Nacional Investigaciones Oncologicas, Madrid, Spain
Please check this section regularly as all the latest IMPACT news will be posted here as soon as the information becomes available.
